隋广超

发布时间:2022-04-12文章来源: 浏览次数:

隋广超教授,博士生导师。

联系方式

E-mail: gcsui@nefu.edu.cn

电话:86-451-8219-1081

地址:黑龙江省哈尔滨市香坊区和兴路26号

东北林业大学生命科学学院(新逸夫教学楼) 117房间

教育和训练经历:

1983/09-1987/07,北京大学,生物系,生物化学专业学士

1990/10-1995/07,北京大学,生命科学学院,生物化学及分子生物学博士

1995/10-1998/11,瑞典Karolinska医学院,临床化学系,医学博士

1998/11-1999/07,瑞典Karolinska医学院,临床化学系,博士后

1999/07-2004/08,美国哈佛大学哈佛医学院,病理系,博士后

工作经历:

2004/09-2005/08,美国哈佛大学哈佛医学院,讲师

2005/09-2012/09,美国Wake Forest大学医学院癌症生物学系,美国NIH综合癌症研究中心,助教授

2012/10-2014/06,美国Wake Forest大学医学院癌症生物学系,美国NIH综合癌症研究中心,副教授

2014-现在,东北林业大学生命科学学院,教授(全职

专业特长:

分子生物学,生物化学,细胞生物学,遗传学及表观遗传学,非编码RNA (noncoding RNA),基因表达及调控,癌症生物学。

研究经验和研究领域:

1)药用植物抑癌活性成分的药效机理研究:药用植物中的很多成分具有抑癌活性,但其药效机理不明,限制其临床应用。为突破该瓶颈,我们将探究植物药用成分在肝癌细胞内的分子靶点、所影响的重要基因及细胞生物途径,创立科学的联合给药方式以有效抑制肝癌发展并降低对机体副作用。首次在细胞水平验证了鞣花酸联合阿霉素或联合顺铂的抗肝癌活性,并在小鼠模型中鉴定了鞣花酸联合阿霉素使用,可以显著加强阿霉素抗肝癌活性,减弱由高浓度下阿霉素引发的心肌毒性。此外,我们还研究了百里香琨,地榆皂苷II的植物天然活性物质的抑癌活性。

2)发明了以DNA载体为基础的RNA干扰(RNAi)技术(即shRNA方法)。这一技术的发明为许多生物学科的研究提供了全新的方法,尤其是对基因和蛋白质功能的研究具有重大的创新性,也进了RNAi技术在医疗上的应用。目前,这一方法已经成为世界范围实验室用于研究基因功能的常规实验技术。该方法的DNA载体成为Ambion/Life Technologies公司的第一代产品(商品名pSilencer)。做为第一作者的相关PNAS文章已被引用上千次。

3)利用对Yin Yang 1(YY1)蛋白在肿瘤发生中功能的研究来探索几种常见癌症(乳腺癌,前列腺癌,肺癌)的致病机制。我的多年的研究成果确立了YY1的癌基因地位。作为一个多功能蛋白,YY1在癌症发生中的终极作用一直有争议。我在2004年发表的Cell文章中发现了YY1对p53的负调控,奠定了YY1的癌基因的地位。这些研究进一步确定YY1的癌基因地位,并揭示了YY1在癌症治疗中作为靶基因的可能性。通过干扰YY1与癌蛋白之间相互作用以抑制肿瘤生长的多肽已被授权专利。

4)对其它抑癌基因、原癌基因及非编码RNA的研究:(1)利用基因芯片等方法对抑癌基因SOX7的研究,发现其上、下游调控因子及可能的调节机制;(2)对DMTF1研究,发现了这一基因产生mRNA的不同选择性剪接(alternative splicing)形态对乳腺癌发生和发展具有完全相反的作用,以及调节该可变剪接的分子机制;(3)研究了几种microRNA对原癌基因EZH2、YY1和FASN的调节作用;(4)利用多个乳腺癌及它们对应的癌旁组织样品中的长非编码RNA(lncRNA)的分析,发现了多种在乳腺癌中差异性表达的lncRNA,目前正在对它们的生物学意义和对乳腺癌的调节功能进行鉴定。

教学情况:

(1)曾经在Wake Forest大学医学院授课:Oncogenes, Tumor suppressors, Cancer Epigenetics, Non-coding RNAs.

(2)表观遗传学与应用(本科生必修课)

(3)留学生课程(全英语):

1)Epigenetics (Cancer-related)

2)Developmental Biology (Animal)

3)Molecular Biology and Biochemistry

(4)负责iGEM指导和培训工作,曾获2014-2016年iGEM银奖;2018年最佳单项奖;2017-2021年iGEM金奖,2021年“最佳wiki制作”单项奖和“最佳医疗诊断项目”赛道奖。

基金评审经历(专家评委, Scientist Reviewer):

*美国国防部(DOD)癌症研究基金评委(2007-2017; 12次)

*美国癌症协会(ACS)研究基金评委(2013)

*意大利健康部(2010, 2013, 2015, 2017)

*英国研究基金(2012)

*美国佛罗里达健康部门基金(2015, 2016)

*中国国家自然科学基金(2019-2021)

*科技部政府间国际科技创新合作和科技部重点研发项目评审(2021)

近年承担的主要课题:

*国家自然科学基金(项目主持人): 2015年01月至2018年12月

题目: SOX7在乳腺癌中调控机制的研究

*黑龙江省自然科学基金重点项目(项目主持人): 2015年07月至2018年06月

题目:利用YY1的OPB肽段抑制肿瘤细胞生长

*国家自然科学基金(项目主持人): 2017年01月至2020年12月

题目:乳腺癌中YY1调节促癌蛋白活性的机制及其应用价值的研究

*国家自然科学基金(项目主持人): 2019年01月至2022年12月

题目:乳腺癌细胞基因组内G-四链体的形成特征及调节因素研究

在美国期间承担过的研究项目(项目主持人: Guangchao Sui):

*美国National Institute of Health (NIH): R01, 2009 - 2014

项目主持人(PI): Guangchao Sui

题目: Dmp1-p53/YY1 interplays and their roles in lung cancer development

*美国American Cancer Society (ACS):Research Scholar Grant, 2009 - 2013

项目主持人(PI): Guangchao Sui

2009 – 2013:The role of YY1 in prostate cancer

其它:

*美国Department of Defense (DOD)前列腺癌研究项目

* Golfers Against Cancer (GAC)

* Kulynych Interdisciplinary Cancer Research Fund

* Cell Growth and Survival Program Push Grant

发表文章: (*为通讯作者)

1. Guang-Chao Sui, Hong Sun, Man Zhang and Mei-Hao Hu.High level expression of recombinant plasminogen activator inhibitor-1 inEscherichia coliand generation of its mutants involving Asp125, Glu128 and Glu130. Biochem. Mol. Biol. Int., (1997) 42(3):621-629.

http://www.ncbi.nlm.nih.gov/pubmed/?term=9247720

2. Guang-Chao Sui and Björn Wiman.Stability of plasminogen activator inhibitor-1: role of Tyrosine221. FEBS Letters, (1998) 423(3):319-323.

http://dx.doi.org/doi:10.1016/S0014-5793(98)00115-X

3. Guang-Chao Sui and Björn Wiman.Functional effects of single amino acid substitutions in the region Phe113 to Asp138 in the PAI-1 molecule. Biochem. J., (1998) 331(2):409-415.

http://www.biochemj.org/bj/331/0409/bj3310409.htm

4. Gunnar Falk, Guang-Chao Sui, Sam Schulman and Björn Wiman.Detection of a new polymorphism in the propeptide region of the PAI-1 gene in two individuals with bleeding tendencies. Fibrinolysis and Proteolysis, (1999) 13(1):26-30.

http://dx.doi.org/doi:10.1016/S0268-9499(99)90012-7

5. Guang-Chao Sui, Helena Mångs and Björn Wiman.The role of His143 to PAI-1 function. Biochim. Biophys. Acta., (1999) 1434(1):58-63.

http://dx.doi.org/doi:10.1016/S0167-4838(99)00157-0

6. Helena Mångs, Guang-Chao Sui and Björn Wiman.PAI-1 stability: role of histidine residues. FEBS Letters, (2000) 475(3):192-196.

http://dx.doi.org/doi:10.1016/S0014-5793(00)01656-2

7. Guang-Chao Sui and Björn Wiman.The B beta-sheet in the PAI-1 molecule plays an important role in regulating its stability. Thrombosis and Haemostasis, (2000) 83(6):896-901.http://www.schattauer.de/index.php?id=1268&L=1&pii=th00060896&no_cache=1

8. Dominica Calvo, Martin Vector, Frederique Gay, Guangchao Sui, Margaret P Luck, Pascle Dufourcq, Gengyun Wen, M Maduro, J Rothman and Yang Shi.A POP-1 repressor complex restricts inappropriate cell type-specific gene transcription duringCaenorhabditis elegansembryogenesis. EMBO. J., (2001) 20(24):7197-7208.

http://dx.doi.org/doi:10.1093/emboj/20.24.7197.

9. Guangchao Sui, Christina Soohoo, El Bachir Affar, Frederique Gay, Yujiang Shi, William C. Forrester, and Yang Shi.A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA, (2002) 99:5515-5520.

http://dx.doi.org/doi:10.1073/pnas.082117599

10. Yujiang Shi, Junichi Sawada, Guangchao Sui, El Bachir Affar, Johnathan R. Whetstine, Fei Lan, Hidesato Ogawa, Margaret Po-Shan Luke, Yoshihiro Nakatani and Yang Shi.Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature, (2003) 422:735-738.

http://dx.doi.org/doi:10.1038/nature01550

11. Guangchao Sui, El Bachir Affar, Yujiang Shi, Chrystelle Brignone, Nathan R. Wall, Peng Yin, Mary Donohoe, Margaret P. Luke, Dominica Calvo, Steven R. Grossman and Yang Shi.Yin Yang 1 is a negative regulator of p53. Cell, (2004) 117:859-872.

http://dx.doi.org/doi:10.1016/j.cell.2004.06.004

12. Peter Baumeister, Shengzhan Luo, William C. Skarnes, Guangchao Sui, Edward Seto, Yang Shi and Amy S. Lee.Endoplasmic reticulum stress induction of the Grp78/BiP promoter: activating mechanisms mediated by YY1 and its interactive chromatin modifiers. Mol. Cell. Biol., (2005) 25:4529-4540.

http://dx.doi.org/doi:10.1128/MCB.25.11.4529-4540.2005

13. Guangchao Sui and Yang Shi.Gene silencing by a DNA vector-based RNAi technology. Methods Mol. Biol., (2005) 309:205-218.

http://dx.doi.org/doi:10.1385/1-59259-935-4:205

14. El Bachir Affar, Margaret Po-shan Luke, Frederique Gay, Dominica, Calvo, Guangchao Sui, Robert S. Weiss, En Li, and Yang Shi.Targeted ablation of Par-4 reveals a cell type-specific susceptibility to apoptosis-inducing agents. Cancer Research. (2006) 66:3456-3462.

http://dx.doi.org/doi:10.1158/0008-5472.CAN-05-0964

15. Margaret P. Luke, Guangchao Sui, Huifei Liu and Yang Shi.Yin Yang 1 physically interacts with HoxA11 and represses HoxA11-depedent transcription. J. Biol. Chem., (2006) 281:33226-33232.

http://dx.doi.org/doi:10.1074/jbc.M606584200

16. Zhiyong Deng, Meimei Wan and Guangchao Sui*.PIASy-mediated sumoylation of Yin Yang 1 depends on their interaction but not the RING finger. Mol. Cell. Biol., (2007) 27(10):3780-3792.

http://dx.doi.org/doi:10.1128/MCB.01761-06

17. Dohoon Kim, Minh Nguyen, Matthew Dobbin, Andre Fischer, Farahnaz Sananbenesi, Joseph Rodgers, Ivana Delalle, Joseph Baur, Guangchao Sui, Sean M Armour, Pere Puigserver, David Sinclair and Li-Huei Tsai.SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J. (2007) 26(13):3169–3179.

http://dx.doi.org/doi:10.1038/sj.emboj.7601758

18. Zhiyong Deng, Meimei Wan, Paul Cao, Anuradha Rao, Scott D. Cramer and Guangchao Sui*. Yin Yang 1 Regulates the Transcriptional Activity of Androgen Receptor. Oncogene; (2009) 28:3746-3757.

http://dx.doi.org/doi:10.1038/onc.2009.231

19. Guangchao Sui*.The regulation of YY1 in tumorigenesis and its targeting potential in cancer therapy. Mol. Cell. Pharmacol. (2009) 1(3):157-176 (Invited review)

http://dx.doi.org/DOI:10.4255/mcpharmacol.09.20

20. Zhiyong Deng, Paul Cao, Meimei Wan and Guangchao Sui*.Yin Yang 1: a multifaceted protein beyond a transcription factor.Transcription. (2010) 1(2):81-84. (Invited review)

http://dx.doi.org/10.4161/trns.1.2.12375

21. Paul Cao, Zhiyong Deng, Meimei Wan, Weiwei Huang, Scott D Cramer, Jianfeng Xu, Ming Lei and Guangchao Sui*.MicroRNA-101 Negatively Regulates Ezh2 and Its Expression is Modulated by Androgen Receptor and HIF-1alpha/HIF-1beta. Mol. Cancer, (2010) 9(1):108.

http://dx.doi.org/doi:10.1186/1476-4598-9-108

22. Linara S. Axanova, Yong Q. Chen, Thomas McCoy, Guangchao Sui and Scott D. Cramer.1,25-dihydroxyvitamin D3 and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells. Prostate. (2010) 70(15):1658-1671.

http://dx.doi.org/doi:10.1002/pros.21201

23. Rui Fang, Andrew J. Barbera, Yufei Xu, Michael Rutenberg, Thiago Leonor, Qing Bi, Fei Lan, Pinchao Mei, Guo-Cheng Yuan, Christine Lian, Junmin Peng, Dongmei Cheng, Guangchao Sui, Ursula B. Kaiser, Yang Shi and Yujiang Geno Shi.Human LSD2/KDM1b/AOF1 Regulates Gene Transcription by Modulating Intragenic H3K4me2 Methylation. Mol. Cell, (2010) 39(2):222-233.

http://dx.doi.org/doi:10.1016/j.molcel.2010.07.008

24. Zandra K. Pinnix, Lance D. Miller, Wei Wang, Ralph D’Agostino Jr., Tim Kute, Mark C. Willingham, Heather Hatcher, Lia Tesfay, Guangchao Sui, Xiumin Di, Suzy V. Torti, Frank M. Torti.Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis.Sci Transl Med. (2012) 22, 43ra56.

http://dx.doi.org/doi:10.1126/scitranslmed.3001127

24. Helen Yu, Nazar Mashtalir, Salima Daou, Ian Hammond-Martel, Julie Ross, Guangchao Sui, Gerald W. Hart, Frank J. Rauscher III, Elliot Drobetsky, Eric Milot, Yang Shi and El Bachir Affar.The Ubiquitin Carboxyl Hydrolase BAP1 Forms a Ternary Complex with YY1 and HCF-1 and is a Critical Regulator of Gene Expression.Mol. Cell. Biol., (2010) 30(21):5071-5085.

http://dx.doi.org/doi:10.1128/MCB.00396-10

26. Salima Daou, Nazar Mashtalir, Ian H Martel, Helen Pak, Helen Yu, Guangchao Sui, Jodi Vogel, Thomas Kristie, El Bachir Affar.Crosstalk Between O-GlcNAcylation And Proteolytic Cleavage Regulates The Host Cell Factor-1 Maturation Pathway. Proc. Natl. Acad. Sci. USA, (2011) 108(7):2747-2752.

http://dx.doi.org/doi:10.1073/pnas.1013822108

27. Sophia L Maund, Wendy W Barclay, Laura D Hover, Linara S Axanova, Guangchao Sui, Jason D Hipp, James C. Fleet, Andrew Thorburn, and Scott D Cramer.Interleukin-1α Mediates the Antiproliferative Effects of 1,25-Dihydroxyvitamin D3 in Prostate Progenitor/Stem Cells. (2011) Cancer Research, 71(15):5276-5286.

http://dx.doi.org/doi:10.1158/0008-5472.CAN-10-2160

28. Qiang Zhang, Daniel Stovall, Kazushi Inoue and Guangchao Sui*.The oncogenic role of Yin Yang 1. Critical Reviews in Oncogenesis, (2011) 16(3-4):163-197. (Invited review)

http://dx.doi.org/DOI:10.1615/CritRevOncog.v16.i3-4.30

29. Weiwei Huang, Philip J. Smaldino, Qiang Zhang, Lance D. Miller, Paul Cao, Kristin Stadelman, Meimei Wan, Banabihari Giri, Ming Lei, Yoshikuni Nagamine, James P. Vaughn, Steven A. Akman and Guangchao Sui*.Yin Yang 1 contains G-quadruplex structures in its promoter and 5’-UTR and its expression is modulated by G4 Resolvase 1. Nucleic Acids Research, (2012) 40(3):1033-1049.

http://dx.doi.org/doi:10.1093/nar/gkr849

30. Shihua Wang, Jiansheng Wu, Janel Suburu, Zhennan Gu, Jiaozhong Cai, Linara S. Axanova, Scott D. Cramer, Michael J. Thomas, Donna L. Perry, Iris Edwards, Lorelei Mucci, Jennifer Sinnott, Massimo Loda, Guangchao Sui, Isabelle M. Berquin and Yong Q. Chen. Effect of Dietary Polyunsaturated Fatty Acids on Castration-resistant Pten-null Prostate Cancer. Carcinogenesis, (2012) 33(2):404-412.

http://dx.doi.org/doi:10.1093/carcin/bgr290

31. Wennuan Liu, Johan Lindberg, Guangchao Sui, Jun Luo, Tao Li, Carol Xie, Meimei Wan, Seong-Tae Kim, Aubrey Turner, Jishan Sun, Yi Zhu, Zheng Zhang, Scott D Cramer, Robert L. Vessella, S. Lilly Zheng, Henrik Grönberg, William B. Isaacs and Jianfeng Xu.Genome-wide analysis of somatic DNA copy number reveals novel CHD1-associated collaborative alterations of genomic structure in prostate cancer. Oncogene, (2012) 31(35):3939-48.

http://dx.doi.org/doi:10.1038/onc.2011.554

32. Caroline I. Schnegg, Mitra Kooshki, Fang-Chi Hsu, Guangchao Sui and Mike E. Robbins. PPARδ prevents radiation-induced proinflammatory responses in microglia via transrepression of NF-кB and inhibition of the PKCα/MEK1/2/ERK1/2/AP-1 pathway. Free Radical Biology and Medicine, (2012) 52:1734-1743.

http://dx.doi.org/10.1016/j.freeradbiomed.2012.02.032

33. Donna P. Frazier, Robert D. Kendig, Fumitake Kai, Dejan Maglic, Takayuki, Sugiyama, Rachel L. Morgan, Sarah J. Lagedrost, Guangchao Sui and Kazushi Inoue. Dmp1 physically interacts with p53 and positively regulates p53’s stability, nuclear localization and transcriptional activity. Cancer Research, (2012) 72:1740-1750.

http://dx.doi.org/doi:10.1158/0008-5472.CAN-11-2410

34. Meimei Wan, Weiwei Huang, Timothy E. Kute, Lance Miller, Qiang Zhang, Heather Hatcher, Jingxuan Wang, Daniel Stovall, Gregory B. Russell, Paul Cao, Zhiyong Deng, Wei Wang, Qingyuan Zhang, Ming Lei, Suzy Torti, Steven A. Akman and Guangchao Sui*. Yin Yang 1 plays an essential role in breast cancer and negatively regulates p27. American Journal of Pathology, (2012) 180(5):2120-2133.

http://dx.doi.org/10.1016/j.ajpath.2012.01.037

35. Min Wu, Lihong Shi, Adela Cimic, Lina Romero, Guangchao Sui, Cynthia J. Lees, J. Mark Cline, Darren F. Seals, Joseph S. Sirintrapun, Thomas P. McCoy, Jielin Sun, Seong-Tae Kim, Wennuan Liu, Donna M. Peehl, Jianfeng Xu, Scott D. Cramer.Suppression of Tak1 promotes prostate tumorigenesis. Cancer Research, (2012) 72(11):2833-2843.

http://dx.doi.org/doi:10.1158/0008-5472.CAN-11-2724

36. Shuai Tang, Meenu Mishra, Donna P. Frazier, Miranda L. Moore, Kazushi Inoue, Rajendar Deora, Guangchao Sui and Purnima Dubey. Positive and negative regulation of prostate stem cell antigen expression by Yin Yang 1 in prostate epithelial cell lines. PLoS One, (2012) 7(4): e35570.

http://dx.doi.org/doi:10.1371/journal.pone.0035570

37. Daniel Stovall and Guangchao Sui*. The Function of YY1 and its Oncogenic Role in Prostate Cancer. In: Gerhard Hamilton, eds.Advances in Prostate Cancer.InTech. 2012:563-587.

http://dx.doi.org/10.5772/53091

38. Daniel Stovall, Meimei Wan, Qiang Zhang, Purnima Dubey and Guangchao Sui*.DNA Vector-based RNA Interference to Study Gene Function in Cancer. Journal of Visualized Experiments, (2012) (64), pii: 4129.

http://dx.doi.org/doi:10.3791/4129

39. Zhiyong Deng, Guangchao Sui, Paulo Mottin Rosa and Weiling Zhao.Radiation-Induced c-Jun Activation Depends on MEK1-ERK1/2 Signaling Pathway in Microglial Cells. PLoS One, (2012) 7(5):e36739.

http://dx.doi.org/doi:10.1371/journal.pone.0036739

40. Wei Wang, David Grier, Jennifer Woo, Martha Ward, Guangchao Sui, Suzy V. Torti, Frank M. Torti, and Michael W. Beaty.Ferritin H is a novel marker of early erythroid precursors and macrophages. Histopathology. (2013) 62(6):931-40.

http://dx.doi.org/ doi:10.1111/his.12101

41. Sinan Zhu, Ryan T. Mott, Elizabeth A. Fry, Pankaj Taneja, George Kulik, Guangchao Sui*, and Kazushi Inoue*.Cooperation between Dmp1-loss and cyclin D1 overexpression in breast cancer.American Journal of Pathology. (2013) 183(4):1339-1350.

http://dx.doi.org/doi:10.1016/j.ajpath.2013.06.027

42. Daniel B. Stovall, Meimei Wan, Lance D. Miller, Paul Cao, Dejan Maglic, Qiang Zhang, Martha R. Stampfer, Wennuan Liu, Jianfeng Xu and Guangchao Sui*.The Regulation of SOX7 and its Tumor Suppressive Role in Breast Cancer.American Journal of Pathology.(2013) 183(5):1645-1653.

http://dx.doi.org/doi:10.1016/j.ajpath.2013.07.025

43. DanaYancey, Kyle C. Nelson, Daniele Baiz, Sazzad Hassan, Anabel Flores, Ashok Pullikuth, Yelena Karpova, Victoria Moore1, Guangchao Sui and George Kulik.BAD Dephosphorylation and Decreased Expression of MCL-1 Induce Rapid Apoptosis in Prostate Cancer Cells. PLoS One. (2013) 8(9):e74561.http://dx.doi.org/doi:10.1371/journal.pone.0074561

44. Daniele Baiz, Sazzad Hassan, Young AChoi, Anabel Flores, Yelena Karpova, Dana Yancey, Ashok Pullikuth, Guangchao Sui, Michel Sadelain, Waldemar Debinski and George Kulik.Combination of the PI3K Inhibitor ZSTK474 with a PSMA-Targeted Immunotoxin Accelerates Apoptosis and Regression of Prostate Cancer. Neoplasia. (2013) 15(10):1720-1183.

http://dx.doi.org/doi:10.1593/neo.13986

45. Elizabeth A. Fry, Pankaj Taneja, Dejan Maglic, Sinan Zhu, Guangchao Sui*, and Kazushi Inoue*.Dmp1α Inhibits HER2/neu-induced Mammary Tumorigenesis. PLoS One. (2013) 8(10):e77870.

http://dx.doi.org/doi:10.1371/journal.pone.0077870

46. Guorui Deng and Guangchao Sui*.Noncoding RNA in Oncogenesis: A New Era of Identifying Key Players. Int. J. Mol. Sci. (2013) 14:18319-18349.(Invited review)

http://dx.doi.org/doi:10.3390/ijms140918319

47. Wei Wang, Zhiyong Deng, Heather Hatcher, Lance D. Miller, Xiumin Di, Lia Tesfay, Guangchao Sui, Ralph B. D'Agostino Jr., Frank M. Torti, and Suzy V. Torti.IRP2 regulates breast tumor growth. Cancer Research. (2014) 74(2):497-507.

http://dx.doi.org/doi:10.1158/0008-5472.CAN-13-1224

48. Nicholas R. Galloway, Carlos J. Diaz Osterman, Karl Reiber, Jessica M.S. Jutzy, Fengzhi Li, Guangchao Sui, Ubaldo Soto, Nathan R. Wall. Yin Yang 1 regulates the transcriptional repression of surviving. Biochem Biophys Res Commun. (2014) 445(1):208-213.

http://dx.doi.org/doi:10.1016/j.bbrc.2014.01.169

49. Daniel B. Stovall, Paul Cao and Guangchao Sui*.SOX7: From a developmental regulator to an emerging tumor suppressor. Histol Histopathol.(2014)29(4):439-445.

http://www.hh.um.es/Abstracts/Vol_29/29_4/29_4_439.htm

50. Dejan Maglic, Daniel B. Stovall, Mark Cline, Elizabeth A. Fry, Ali Mallakin, Pankaj Taneja, David L. Caudell, Mark C. Willingham, Guangchao Sui*, and Kazushi Inoue*. DMP1β, a splice isoform of the tumor suppressor DMP1 locus, induces proliferation and progression ofbreast cancer. J. Pathol.(2015) 236(1):90-102.

http://dx.doi.org/doi:10.1002/path.4504

51. Jinming Shi, Aixin Hao, Qiang Zhang, and Guangchao Sui*. The Role of YY1 in Oncogenesis and Its Potential as a Drug Target in Cancer Therapies. Current Cancer Drug Targets.(2015)15(2):145-157.

http://dx.doi.org/10.2174/1568009615666150131124200

52. Qiang Zhang, Meimei Wan, Jinming Shi, David A. Horita, Lance D. Miller, Timothy E. Kute, Steven J. Kridel, George Kulik, and Guangchao Sui*. Yin Yang 1 Promotes mTORC2-mediated AKT Phosphorylation. J. Mol. Cell. Biol.(2016)8(3):232-243.

http://dx.doi.org/doi:10.1093/jmcb/mjw002

53. Jingxuan Wang, Xiao Zhang, Jinming Shi, Paul Cao, Meimei Wan, Qiang Zhang, Yunxuan Wang, Steven J. Kridel, Wennuan Liu, Jianfeng Xu, Qingyuan Zhang and Guangchao Sui*. Fatty Acid Synthase is a Primary Target of MiR-15a and MiR-16-1 in Breast Cancer. Oncotarget.(2016)7(48):78566-78576.

http://dx.doi.org/doi:10.18632/oncotarget.12479

54. Na Tian, Jialiang Li, Jinming Shi and Guangchao Sui*. From General Aberrant Alternative Splicing in Cancers and Its Therapeutic Application to the Discovery of an Oncogenic DMTF1 Isoform. (2017) Int. J. Mol. Sci. 18(191):1-20.

http://dx.doi.org/doi:10.3390/ijms18030191

55. Wenmeng Wang, Dangdang Li and Guangchao Sui*. YY1 Is an Inducer of Cancer Metastasis. Crit. Rev. Oncog.(2017)22(1-2):1-11.

http://dx.doi.org/doi:10.1615/CritRevOncog.2017021314

56. Li Yao*, Heming Wang, Yuanyuan Song and Guangchao Sui*. BioQueue: a novel pipeline framework to accelerate bioinformatics analysis. Bioinformatics.(2017)33(20):3286-3288.

http://dx.doi.org/doi:10.1093/bioinformatics/btx403

57. Chen Zhong, Nathan R. Wall, Yuangang Zu and Guangchao Sui*. Therapeutic Application of Natural Medicine Monomers in Cancer Treatment. Curr. Med. Chem.(2017)24(34):3681-3691.http://dx.doi.org/doi:10.2174/0929867324666170714101503

58. Yumeng Zhang, Daniel B. Stovall, Meimei Wan, Qiang Zhang, Jeff W. Chou, Dangdang Li and Guangchao Sui*. SOX7 Target Genes and Their Contribution to Its Tumor Suppressive Function. Int. J. Mol. Sci.(2018)19(5):pii: E1451.http://dx.doi.org/doi:10.3390/ijms19051451

59. Yingzhou Li, Xiao Zhang, Yang Gao, Jiming Shi, Liping Tang* and Guangchao Sui*. G-quadruplexes in the BAP1 promoter positively regulate its expression. Exp. Cell. Res. (2018) 369(1):147-15.

http://dx.doi.org/doi:10.1016/j.yexcr.2018.05.016

60. Jeffrey P Chmielewski, Sarah Bowlby, Frances Wheeler, Lihong Shi, Guangchao Sui, Amanda L. Davis, Timothy Howard, Ralph B. D'Agostino, Lance Miller, S. Joseph Sirintrapun, Scott Cramer and Steven J. Kridel. CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD+ Pools. Mol. Cancer. Res. (2018) 16(11):1687-1700.

http://dx.doi.org/DOI:10.1158/1541-7786.MCR-17-0526

61. Xiao Zhang, Bo Zhao, Ting Yan, Aixin Hao, Yang Gao, Dangdang Li and Guangchao Sui*. G-Quadruplex Structures at the Promoter of HOXC10 Regulate its Expression. BBA-Gene Regul. Mech., (2018) 1861(11):1018-1028.

http://dx.doi.org/doi:10.1016/j.bbagrm.2018.09.004

62. Yige Qi, Ting Yan, Lu Chen, Qiang Zhang, Weishu Wang, Xu Han, Dangdang Li, Jinming Shi and Guangchao Sui*. Characterization of YY1 OPB Peptide for Its Anticancer Activity, Current Cancer Drug Targets, (2019) 19(6):504-511.

http://dx.doi.org/doi:10.2174/1568009618666181031153151

63. Chen Zhong, Shuang Qiu, Jialiang Li, Jingling Shen, Yuangang Zu, Jinming Shi* and Guangchao Sui*. Ellagic acid synergistically potentiates inhibitory activities of chemotherapeutic agents to human hepatocellular carcinoma.Phytomedicine,(2019)59:152921.

http://dx.doi.org/doi:10.1016/j.phymed.2019.152921

64. Kuida Chen, Yao Lu, Ke Shi, Daniel B. Stovall, Dangdang Li and Guangchao Sui*. Functional analysis of YY1 zinc fingers through cysteine mutagenesis. FEBS Letters,(2019)593(12):1392-1402.

http://dx.doi.org/doi:10.1002/1873-3468.13431

65. Shuting Lu, Liping Liu, Henan Wang, Wancheng Zhao, Zeyu Li, Zheng Qu, Jialu Li, Tiedong Sun, Ting Wang and Guangchao Sui. Synthesis of dual functional gallic-acid-based carbon dots for bioimaging and antitumor therapy. Biomaterials Science,(2019)7(8):3258-3265.

http://dx.doi.org/doi:10.1039/c9bm00570f

66. Ting Yan, Bo Zhao, Qiong Wu, Wenmeng Wang, Jinming Shi, Dangdang Li, Daniel B. Stovall and Guangchao Sui*. Characterization of G-quadruplex formation in theARID1A promoter. Int J Biol Macromol. (2020) 147:750-761.

http://dx.doi.org/doi:10.1016/j.ijbiomac.2020.01.210

67. Dangdang Li, Daniel B. Stovall B, Wenmeng Wang and Guangchao Sui*. Advances of Zinc Signaling Studies in Prostate Cancer. Int J Mol Sci. (2020) 21(2):667.

http://dx.doi.org/doi:10.3390/ijms21020667

68. Tianyan Liu, Yu Zhang, Yukai Cao, Shan Jiang, Rui Sun, Jiechao Yin, Zhenqiu Gao, Guiping Ren, Zhenzhong Wang, Qingzhong Yu, Guangchao Sui, Xu Sun, Wenying Sun, Wei Xiao and Deshan Li. Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic viruses. Gene Therapy. (2020) 28(12):697-717.

http://dx.doi.org/doi:10.1038/s41434-020-0145-9

69. Yunxuan Wang, Ting Yan, Jialiang Li, Wenmeng Wang, Qiong Wu, Jinming Shi, Dangdang Li, Daniel B. Stovall, Qingyuan Zhang* and Guangchao Sui*. The SNAIL1 promoter contains G-quadruplex structures regulating its gene expression and DNA replication. Exp Cell Res. (2020) 394(2):112158.

http://dx.doi.org/doi:10.1016/j.yexcr.2020.112158

70. Wenmeng Wang, Shuangli Hu, Yaru Gu, Yunxiao Yan, Daniel B. Stovall, Dangdang Li* and Guangchao Sui*. Human MYC G-quadruplex: From discovery to a cancer therapeutic target. Biochim Biophys Acta - Rev Cancer. (2020) 1874(2):188410.

http://dx.doi.org/doi:10.1016/j.bbcan.2020.188410

71. Shah Jehan, Chen Zhong, Guangyue Li, Syed Zulqarnain Bakhtiar, Dangdang Li* and Guangchao Sui*. Thymoquinone selectively induces hepatocellular carcinoma cell apoptosis in synergism with clinical therapeutics and dependence of p53 status. Front Pharmacol., (2020) 11:555283.

http://dx.doi.org/doi:10.3389/fphar.2020.555283

72. Sazzad Hassan, Ashok Pullikuth, Kyle C Nelson, Anabel Flores, Yelena Karpova, Daniele Baiz, Sinan Zhu, Guangchao Sui, Yue Huang, Ralph D'Agostino, Ashok Hemal, Urs von Holzen, Waldemar Debinski and George Kulik. Beta2-adrenoreceptor signaling increases therapy-resistance in prostate cancer by upregulating MCL1. (2020) Mol Cancer Res, 18(12):1839-1848.

http://dx.doi.org/doi:10.1158/1541-7786.MCR-19-1037

73. Jialiang Li, Ke Shi, Tianqi Xu, Jingru Hu, Tianxin Li, Guangyue Li, Kuida Chen, Dangdang Li, Kazushi Inoue and Guangchao Sui*. Mechanisms regulating DMTF1β/γ expression and their functional interplay with DMTF1α. Int J Oncol., (2020) 58(1):20-32.

http://dx.doi.org/doi:10.3892/ijo.2020.5146

74. Aixin Hao, Yu Wang, Xiao Zhang, Jialiang Li, Yingzhou Li, Dangdang Li, George Kulik and Guangchao Sui*. Long Non-coding Antisense RNA HYOU1-AS is Essential to Human Breast Cancer Development Through Competitive Binding hnRNPA1 to Promote HYOU1 Expression. Biochim Biophys Acta - Mol Cell Res. (2021) 1868(4):118951.

http://dx.doi.org/doi:10.1016/j.bbamcr.2021.118951

75. Qiong Wu, Bo Zhao, Guangchao Sui* and Jinming Shi*. Phytochemicals block glucose utilization and lipid synthesis to counteract metabolic reprogramming in cancer cells. Applied Sciences.(2021)11:1259.

https://doi.org/10.3390/app11031259

76. Albert Gyapong Aduhene, Hongliang Cui, Hongyi Yang, Chengwei Liu, Guangchao Sui* and Changli Liu*. Poly(3-hydroxypropionate): Biosynthesis Pathways and Malonyl-CoA Biosensor Material Properties. Front Bioeng Biotech.(2021)9:646995.

http://dx.doi.org/doi:10.3389/fbioe.2021.646995

77. Shuang Qiu, Chen Zhong, Bo Zhao, Guangyue Li, Jinhua Wang, Shah Jehan, Jialiang Li, Xudong Zhao, Dangdang Li and Guangchao Sui*. Transcriptome Analysis of Signaling Pathways Targeted by Ellagic Acid in Hepatocellular Carcinoma Cells.Biochim Biophys Acta – General Subjects.(2021)1865(7):129911.

http://dx.doi.org/doi:10.1016/j.bbagen.2021.129911

78. Lanlan Zhang, Ting Yan, Wenmeng Wang, Qiong Wu, Guangyue Li, Dangdang Li, Daniel B Stovall, Yunxuan Wang, Yuhua Li* and Guangchao Sui*. AKT1 is positively regulated by G-quadruplexes in its promoter and 3'-UTR. Biochem Biophys Res Commun. (2021) 561:93-100.

http://dx.doi.org/doi:10.1016/j.bbrc.2021.05.029

79. Cheng Yi, Guangyue Li, Wenmeng Wang, Yixuan Sun, Yueling Zhang, Chen Zhong, Daniel B. Stovall, Dangdang Li, Jinming Shi* and Guangchao Sui*. Disruption of YY1-EZH2 Interaction Using Synthetic Peptides Inhibits Breast Cancer Development. Cancers. (2021) 13(10):2402.

http://dx.doi.org/doi:10.3390/cancers13102402

80. Jialiang Li, Guangyue Li, Yige Qi, Yao Lu, Hao Wang, Ke Shi, Dangdang Li, Jinming Shi, Daniel B. Stovall and Guangchao Sui*. SRSF5 Regulates Alternative Splicing of DMTF1 pre-mRNA through Modulating SF1 Binding. RNA Biology. (2021) 18(sup1):318-336.

http://dx.doi.org/doi:10.1080/15476286.2021.1947644

81. Aixin Hao, Yunxuan Wang, Daniel B. Stovall, Yu Wang* and Guangchao Sui*. Emerging Roles of LncRNAs in the EZH2-regulated Oncogenic Network. Int J Biol Sci. (2021)17(13):3268-3280.

http://dx.doi.org/doi:10.7150/ijbs.63488

82. Bo Zhao, Jinyan Zhao, Mingshuai Lv, Xiaoyan Li, Jinhua Wang, Zhengrong Yue, Jinming Shi, Guocai Zhang* and Guangchao Sui*. Comparative study of structural properties and biological activities of polysaccharides extracted from Chroogomphus rutilus by four different approaches. Int J Biol Macromol. (2021)188:215-225.

http://dx.doi.org/doi:10.1016/j.ijbiomac.2021.08.025

83. Jinhua Wang, Dangdang Li, Bo Zhao, Juhyok Kim, Guangchao Sui* and Jinming Shi*. Small Molecule Compounds of Natural Origin Target Cellular Receptors to Inhibit Cancer Development and Progression. (2022). Int J Mol Sci. 23:2672.

https://doi.org/10.3390/ijms23052672

84. Shiyao Qiao, Wenmeng Wang, Cheng Yi, Qingqing Xu, Wenfei Wang, Jinming Shi, Daniel B. Stovall, Dangdang Li and Guangchao Sui*. YY1 Oligomerization Is Regulated by Its OPB Domain and Competes with Its Regulation of Oncoproteins. (2022) Cancers. 14, 1611.

https://doi.org/10.3390/cancers14071611

85. Wenmeng Wang, Shiyao Qiao, Guangyue Li, Jiahui Cheng, Cuicui Yang, Chen Zhong, Daniel B. Stovall, Jinming Shi, Chunbo Teng, Dangdang Li* and Guangchao Sui*. A histidine cluster determines YY1-compartmentalized coactivators and chromatin elements in phase-separated enhancer clusters. (2022) Nucleic Acids Res. (online ahead of print).

https://doi.org/10.1093/nar/gkac233

著作:

Yin Yang 1 in Metastasis,Critical Reviews™ in Oncogenesis, 22(1-2), 2017.Begell House Inc. Invited editor:Guangchao Sui.http://dx.doi.org/doi:10.1615/CritRevOncog.v22.i1-2

发明专利:

1.发明人:Yang Shi andGuangchao Sui.Compositions and Methods of Suppressing Eukaryotic Gene Expression. Publication of US20030180756A1

https://patents.google.com/patent/US20030180756A1/en

2.发明人:隋广超

发明专利:一种具有抗癌活性的OPB寡肽及其表达载体和应用

专利号:ZL 2016 1 0018929.6

授权公告号:CN 105601724 B

3.发明人:隋广超,易诚,史金铭,李当当

发明专利:利用YPB肽段抑制乳腺癌细胞增殖及肿瘤生长的方法和应用

申请号:202011128751.3

申请日:2020年10月20日

 

关闭 打印责任编辑:闫绍鹏
http://job.nefu.edu.cn/Zhaopin/zhaopinList.html?type=1

友情链接